Alimera Sciences Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Toronto, Ontario--(Newsfile Corp. - May 15, 2013) - Leading smallcap investor portal Smallcappower is pleased to highlight Alimera Sciences Inc (NASDAQ: ALIM) as their Daily Momentum Gainer to watch. You can see the chart and view the analyst's summary here: http://www.smallcappower.com/posts/article-top-momentum-gainer-15-5-2013.

During yesterday's trading session, ALIM was the top gainer in the U.S. healthcare space having gained 22% and closed the day at its 52-week high of $4.84 recording significant volumes of 922,026 shares. During the past 5 trading sessions, ALIM surged 60% with 5-day average volume of 276,459 shares, while the stock accumulated 81% during the past month with 1-Month average volume of 63,292 shares. On May 8, 2013, ALIM announced that its UK subsidiary, Alimera Sciences Limited, secured a debt facility of up to $20 million, which will strengthen ALIM's financial position for the commercialization of ILUVIEN, an intravitreal implant containing fluocinolone acetonide (FAc) for the treatment of ocular disease, in the UK, Germany and France.

About SmallCapPower.com: SmallCapPower.com (SCP) is the industry's most trusted resource for small cap stocks, offering unprecedented access to the research and tools you need to help uncover the next big thing. Through a unique Post Media branding association, this online platform gets coast-to-coast media exposure in nine daily newspapers as well as the Nationalpost.com and Financialpost.com websites. SmallCapPower.com is also the exclusive online destination to access Ubika Research reports, CEO video interviews and analysis.

Disclosure: Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

Ubika Research and www.smallcappower.com (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit: http://www.smallcappower.com/pages/small-cap-power-disclosure.

For additional information contact:
SmallCapPower- info@smallcappower.com